Results 261 to 270 of about 342,678 (334)
Global research trends of tumor microenvironment in non-small cell lung cancer with epidermal growth factor receptor mutation: a bibliometric analysis from 2014 to 2023. [PDF]
Chang X, Wang C, Wang F, Zhang L.
europepmc +1 more source
EGFR-mutated lung cancer as a secondary neoplasm in a patient with Li-Fraumeni syndrome: case report
D Valenzuela+3 more
openalex +1 more source
Electric Pulse Regulated MXene Based Nanozymes for Integrative Bioelectricity Immuno‐Cancer Therapy
MXenzyme‐mediated bioelectricity cancer therapy (MXenzyme‐BECT) enhances cancer cell death through irreversible depolarization, ion channel disruption, ROS generation, and immunogenic cell death. Computational simulations reveal the electrical mechanisms by which MXenzyme acts on single cells and support to predict treatment parameters. Next‐generation
Sanghee Lee+6 more
wiley +1 more source
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma. [PDF]
Lucà S+10 more
europepmc +1 more source
A multifunctional hydroxyapatite (HAp) coating integrated with silver‐gallium liquid metal nanoparticles (HAp‐Ag‐GaNPs) exhibits dual antibacterial and osteogenic properties. It effectively inhibits Gram‐positive and Gram‐negative bacteria, including resistant strains, while enhancing bone regeneration.
Ngoc Huu Nguyen+17 more
wiley +1 more source
New insights on Galectin-9 expression in cancer prognosis: An updated systemic review and meta-analysis. [PDF]
So CY, Li Y, Chow KT.
europepmc +1 more source
H2O2‐Generating Advanced Nanomaterials for Cancer Treatment
H2O2‐generating nanoplatforms can exploit tumor redox imbalance for O2 and toxic reactive oxygen species generation, leading to hypoxia reversal, and apoptosis of cancer cells, respectively. This review highlights the mechanisms of these nanoplatforms, including exogenous H₂O₂ delivery, endogenous amplification, and metal peroxides, which leads to ...
Kiyan Musaie+8 more
wiley +1 more source
Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression. [PDF]
Cai J+5 more
europepmc +1 more source